NCT00284206View on ClinicalTrials.gov

A Trial of Long-Acting Injectable Risperidone in the Treatment of Methamphetamine Dependence

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions
Methamphetamine Dependence
Interventions
DRUG

long-acting injectable risperidone

Trial Locations (1)

98108

VA Puget Sound Health Care System, Addictions Treatment Center, Seattle

All Listed Sponsors
collaborator

Janssen, LP

INDUSTRY

lead

Seattle Institute for Biomedical and Clinical Research

OTHER

NCT00284206 - A Trial of Long-Acting Injectable Risperidone in the Treatment of Methamphetamine Dependence | Biotech Hunter | Biotech Hunter